Pacira BioSciences, Inc. Common Stock
$23
USD
Last updated on --.
24h volume371.25K
24h highest23.7150 USD
24h lowest22.9400 USD
24h Price movement-1.54%
PCRX recent prices
24 Hours
-1.54%-$0.36
30 days
+1.41%+$0.325
60 days
-2.89%-$0.695
90 days
+0.64%+$0.15
Key data
Previous close23.3600 USD
Market cap895.17M USD
Volume371.25K
P/E ratio174.220000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.13000 USD
Net income (FY)5.14M USD
Revenue (FY)734.86M USD
Last report dateApr 30, 2026
About Pacira BioSciences, Inc. Common Stock
HeadquartersBRISBANE
Employees (FY)829.00
Revenue per employee (FY)886.45K USD
Net income per employee (FY)6.20K USD
Listed onNasdaq
PCRX conversion tables
 |  |
|---|---|
| 0.5 PCRX | 11.5 USD |
| 1 PCRX | 23 USD |
| 5 PCRX | 115 USD |
| 10 PCRX | 230 USD |
| |
|---|---|
| 0.5 USD | 0.021739 PCRX |
| 1 USD | 0.043478 PCRX |
| 5 USD | 0.21739 PCRX |
| 10 USD | 0.43478 PCRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PCRX is trading at $23.00, -1.54% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PCRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PCRX is currently trading at $23.00, -1.54% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PCRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PCRX's P/E ratio is currently 174.220000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PCRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PCRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Pacira BioSciences, Inc. Common Stock's market cap is currently 895.17M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume371.25K
24h highest23.7150 USD
24h lowest22.9400 USD
24h Price movement-1.54%
Start trade with PCRX Perpetual
Sign up to trade